Associate Professor Thomas Oxley MBBS BMedSc FRACP PhD is a vascular and interventional neurologist and world expert in brain computer interfaces. He is Associate Professor and Joint Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia, as well as Clinical Instructor, Attending in the Department of Neurosurgery, Mount Sinai Hospital.
Dr Oxley has performed over 1600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. Dr Oxley has published over 100 internationally peer reviewed articles in journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine and The Lancet.
Dr Oxley is the founding CEO of Synchron, a brain data transfer company based in Brooklyn, NY and has raised over US$145M in both private funding and grants. Synchron is developing the leading endovascular implantable brain computer interface, StentrodeTM, a system that aims to provide a treatment for debilitating medical illnesses and enable patients to feel empowered by reconnecting online in ways that can dramatically improve their lives.
In 2022, Dr Oxley and Synchron commenced an FDA-approved clinical trial on the Stentrode motor neuroprosthesis that is paving the way towards first FDA marketing approval for an implanted brain computer interface.